Telix Pharmaceuticals：ITM交易或强化长期买入理由 (NASDAQ:TLX)
· seekingalpha.com
Telix Pharmaceuticals维持买入评级，得益于强劲的2026年第三季度业绩和战略性的ITM收购。在此了解更多关于TLX股票的信息。
Since my previous coverage on Telix Pharmaceuticals Limited ( TLX ), the stock has had a few ups and downs, but for the most part, it’s trading around similar...